Mounjaro in Calgary: Dual GIP/GLP-1 Tirzepatide From Alberta Physicians
Mounjaro in Calgary is the most-discussed GLP-1 of 2026 — a once-weekly dual GIP and GLP-1 receptor agonist manufactured by Eli Lilly that has produced the highest average weight loss of any approved metabolic agent, with SURMOUNT-1 participants losing 15.0-22.5% of body weight over 72 weeks. TelePlus Care offers Calgary-area patients same-day virtual consultations with Alberta-licensed physicians who assess eligibility, review your bloodwork, and issue a prescription you fill at any Calgary pharmacy — from the Shoppers Drug Mart on 17th Avenue to a Co-op pharmacy in Mahogany or Auburn Bay. We serve patients across the city and the broader Calgary Region including Airdrie, Cochrane, and Okotoks.
Book Your Appointment Now
Mounjaro (tirzepatide) received Health Canada Notice of Compliance in November 2022 for Type 2 diabetes; off-label weight-loss prescribing is legal at BMI 30+, or BMI 27+ with comorbidity. Pens cost CA$400-700 every four weeks at Calgary pharmacies in 2026 depending on dose. TelePlus Care provides virtual Calgary consultations and issues prescriptions you fill at any Alberta pharmacy.
- Health Canada approved Mounjaro (tirzepatide) via Notice of Compliance in November 2022 for Type 2 diabetes management.
- Mounjaro costs CA$400-700 per 4-week supply (4 pens) at Calgary pharmacies in 2026, depending on dose strength (2.5, 5, 7.5, 10, 12.5, 15 mg).
- Eligibility for off-label weight management: BMI 30+ kg/m squared, or BMI 27+ with at least one weight-related comorbidity (hypertension, dyslipidemia, sleep apnea, prediabetes).
- Mechanism: dual GIP and GLP-1 receptor agonist — the only dual incretin therapy approved in Canada; SURMOUNT-1 showed 15.0-22.5% body weight loss at 72 weeks.
What Is Mounjaro and Why Is the Dual Mechanism Different?
Mounjaro contains tirzepatide, a single molecule that activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor — making it the only dual incretin therapy approved in Canada. GLP-1 activation slows gastric emptying, reduces appetite signalling in the hypothalamus, and triggers meal-stimulated insulin release; GIP activation enhances insulin sensitivity and is thought to amplify the metabolic and weight-loss effects beyond GLP-1 alone. In head-to-head and meta-analytic comparisons against semaglutide, the dual mechanism produces greater average weight loss and HbA1c reduction. Mounjaro is administered as a once-weekly subcutaneous injection using a single-use pre-filled pen, which most Calgary patients self-administer at home.
Who Qualifies for Mounjaro in Calgary?
Mounjaro's Health Canada-approved indication is Type 2 diabetes. Off-label prescribing for chronic weight management is legal across Canada when clinically justified, and most Calgary physicians follow Obesity Canada's 2020 Clinical Practice Guidelines.
- Adults with confirmed Type 2 diabetes (HbA1c 6.5%+ or fasting glucose 7.0 mmol/L+).
- Adults with Body Mass Index of 30 kg/m squared or greater (Class I obesity or higher).
- Adults with BMI of 27 kg/m squared or greater plus at least one weight-related comorbidity — hypertension, dyslipidemia, sleep apnea, or prediabetes.
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
- No history of pancreatitis.
- Not currently pregnant or planning pregnancy within two months.
- Note: Zepbound (the weight-loss-specific tirzepatide brand sold in the US) is not yet available in Canada in 2026; Calgary patients access tirzepatide as Mounjaro, prescribed off-label for chronic weight management.
The Virtual Consultation Process at TelePlus Care
Calgary patients complete the assessment virtually with Alberta-licensed physicians. Each prescription is documented and shared with your family doctor on request. We don't dispense medication — we issue prescriptions you fill at any Calgary pharmacy.
- Step 1: Book online — most Calgary patients secure a same-day or next-business-day appointment.
- Step 2: Complete an intake form covering medical history, BMI, comorbidities, prior weight-loss attempts, and goals.
- Step 3: Secure video consultation (15-25 minutes) with your Alberta-licensed physician.
- Step 4: Bloodwork review or new requisition through Calgary Lab Services / Alberta Precision Laboratories if labs are older than 12 months.
- Step 5: Prescription issued for any Calgary pharmacy. Your physician will discuss starting dose (typically 2.5 mg) and the gradual titration schedule.
- Step 6: Structured follow-ups at 4, 12, and 24 weeks for titration, side-effect management, and progress review.
Required Bloodwork Before Starting Mounjaro
Standard practice requires recent metabolic and organ-function labs. Calgary Lab Services / Alberta Precision Laboratories collection sites are widely available across the city — downtown, Beltline, Bridgeland, Hillhurst, Marda Loop, McKenzie Towne, Royal Oak, Tuscany, and near South Health Campus — and AHCIP covers medically necessary tests for Alberta residents. EFW Radiology and Mayfair Diagnostics handle imaging if needed.
- HbA1c — required for diabetes diagnosis or screening; baseline for monitoring.
- Fasting plasma glucose.
- Lipid profile — total cholesterol, LDL, HDL, triglycerides.
- Kidney function — eGFR and serum creatinine.
- Liver enzymes — ALT and AST.
- TSH — thyroid screening when weight changes are unexplained.
- Pregnancy test for women of reproductive age.
Cost of Mounjaro in Calgary (2026)
Mounjaro pricing scales with dose strength. Pens are single-use and supplied as 4 per 4-week box. Costs at Calgary pharmacies in 2026 are competitive with Wegovy at lower doses and somewhat higher at maintenance doses.
- Mounjaro 2.5 mg / 5 mg pens (4 weeks): CA$400-500.
- Mounjaro 7.5 mg / 10 mg pens (4 weeks): CA$500-600.
- Mounjaro 12.5 mg / 15 mg pens (4 weeks): CA$600-700.
- Annual cost without insurance at maintenance: approximately CA$7,000-8,400.
- TelePlus Care consultation: covered by AHCIP for Alberta residents; $80 for out-of-province virtual visits.
- AHCIP does not cover Mounjaro for weight loss. For Type 2 diabetes, most private plans (Sun Life, Manulife, Canada Life, Green Shield, Alberta Blue Cross employer plans) cover Mounjaro with prior authorization; weight-loss coverage varies. Confirm using DIN 02531547.
Side Effects of Mounjaro
Mounjaro shares the GLP-1 side-effect profile, with most events appearing during titration and resolving within 8-12 weeks. The dual-receptor mechanism does not appear to introduce categorically new safety concerns relative to semaglutide.
- Nausea — most common; affects 25-35% during titration.
- Diarrhea or constipation.
- Vomiting, particularly during dose increases.
- Decreased appetite — usually desired but can be pronounced.
- Injection site reactions — minor redness or itching.
- Hypoglycemia risk in patients on insulin or sulfonylureas.
- Rare: pancreatitis — severe abdominal pain radiating to the back; seek urgent care at Foothills Medical Centre, Peter Lougheed Centre, Rockyview General, or South Health Campus.
- Rare: gallbladder problems including gallstones.
- Rare: acute kidney injury secondary to dehydration; maintain fluid intake.
Mounjaro Compared to Wegovy, Ozempic, and Saxenda
Mounjaro consistently outperforms semaglutide on average weight loss in clinical trials, but cost, supply, and insurance coverage are deciding factors for many Calgary patients.
- Mounjaro (tirzepatide, weekly) — ~15.0-22.5% body weight loss at 72 weeks (SURMOUNT-1). Highest efficacy in head-to-head data.
- Wegovy (semaglutide 2.4 mg, weekly) — ~14.9% at 68 weeks. On-label for weight loss but supply intermittent.
- Ozempic (semaglutide 2.0 mg, weekly) — ~12-15%, off-label for weight loss, most reliable supply at Calgary pharmacies.
- Saxenda (liraglutide 3.0 mg, daily) — ~8.0% at 56 weeks, decade of safety data, may be more readily covered.
- Mounjaro is often preferred when efficacy is the priority and insurance permits coverage; Ozempic may be preferred when supply or coverage favours semaglutide.
Why Calgary Patients Choose TelePlus Care for Mounjaro
TelePlus Care offers Calgary-area adults timely, evidence-based access to all Health Canada-approved metabolic therapies — including the newest dual incretin agent. Our physicians are a licensed Alberta physician and follow Obesity Canada and Diabetes Canada guidelines. We don't dispense medication — we issue prescriptions you fill at any Calgary pharmacy, whether that's a Shoppers Drug Mart in the Beltline, a London Drugs in Marda Loop, a Co-op pharmacy in Mahogany, or a Sobeys/Safeway in Bridgeland or Royal Oak. Same-day virtual visits, transparent pricing, AHCIP-covered lab requisitions, and structured follow-ups are standard. If Mounjaro is the right molecule for you, we can usually have you started within 24-48 hours.
Your Fast and Convenient Healthcare Solution
Connect with a licensed healthcare provider from the comfort of your home. No referral needed — book your virtual appointment today.
Book Your Appointment Now
Serving Communities Across Alberta
Calgary, Airdrie, Cochrane, Okotoks, Chestermere, High River, and surrounding Bow Valley and Calgary Region communities.
Teleplus care clinic is not an urgent care clinic. If you have an emergency please call 911 or go to the nearest urgent care facility.
